Tickro Technologies Ltd. announced today that they were approved to continue trading on OTCQB Marketplace, which allows for a continuous public market for trading shares through and electronic broker-dealers. Investors can have real-time quotes and market information on the company through http://www.otcmarkets.com/stock/TIKRF/quote
The OTCQB Marketplace includes U.S. and international companies in venture stage, and early development meaning companies on this platform are current in their reporting and undergo an annual verification and management certification process. Tikcro’s symbol will remain TIKRF
About Tickro Technologies
Tickro Technologies Ltd. (OTCQB: TIKRF) supports early stage development in growth areas, with a focus on biotechnology projects originated in Israeli academic centers. The Company is currently engaged with development of certain antibodies selected and verified in pre-clinical trials with a focus on antibodies binding to cancer immune checkpoints. Investors can find real-time quotes and market information on www.otcmarkets.com
For more information about the Company, visit Tickro’s website at www.tickro.com.
Safe Harbor Statement
Certain of the statements contained herein may be considered forward-looking statements that involve risks and uncertainties including, but not limited to, risks related to our ability to raise financing and the risks related to early stage biotechnology projects, including, but not limited to, the development, testing, regulatory approval and commercialization, intellectual property rights, competition, exposure to lawsuits and dependence on key suppliers and personnel. Such risks and uncertainties are set forth in the Company’s SEC reports, including the Company’s Forms 20-F. Actual results may materially differ. Results of operations in any past period should not be considered indicative of the results to be expected for future periods. We undertake no duty to update any forward-looking information.